Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Analysis 6.5. Comparison 6 Artesunate plus mefloquine vs Artemether-lumefantrine, Outcome 5 P. vivax<br />
parasitaemia.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 6 Artesunate plus mefloquine vs Artemether-lumefantrine<br />
Outcome: 5 P. vivax parasitaemia<br />
Study or subgroup AS+MQ AL6 Risk Ratio Risk Ratio<br />
1 Mixed P. falciparum and vivax infection at baseline<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Lefevre 1999 THA 7/55 16/164 1.30 [ 0.57, 3.00 ]<br />
Hutagalung 2002 THA 0/245 0/245 0.0 [ 0.0, 0.0 ]<br />
Van den Broek 2003a BGD 0/121 0/121 0.0 [ 0.0, 0.0 ]<br />
Stohrer 2003 LAO 0/55 0/53 0.0 [ 0.0, 0.0 ]<br />
Mayxay 2003 LAO 0/110 0/110 0.0 [ 0.0, 0.0 ]<br />
Subtotal (95% CI) 586 693 1.30 [ 0.57, 3.00 ]<br />
Total events: 7 (AS+MQ), 16 (AL6)<br />
Heterogeneity: Chi 2 = 0.0, df = 0 (P = 1.00); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 0.62 (P = 0.53)<br />
2 P. vivax parasitaemia by day 28<br />
Lefevre 1999 THA 0/53 6/155 0.22 [ 0.01, 3.88 ]<br />
Subtotal (95% CI) 53 155 0.22 [ 0.01, 3.88 ]<br />
Total events: 0 (AS+MQ), 6 (AL6)<br />
Heterogeneity: not applicable<br />
Test <strong>for</strong> overall effect: Z = 1.03 (P = 0.30)<br />
3 P. vivax parasitaemia by day 42<br />
Hutagalung 2002 THA 29/227 90/225 0.32 [ 0.22, 0.47 ]<br />
Mayxay 2003 LAO 0/108 5/107 0.09 [ 0.01, 1.61 ]<br />
Van den Broek 2003a BGD 6/114 26/119 0.24 [ 0.10, 0.56 ]<br />
Stohrer 2003 LAO 1/54 2/49 0.45 [ 0.04, 4.85 ]<br />
Subtotal (95% CI) 503 500 0.30 [ 0.21, 0.41 ]<br />
Total events: 36 (AS+MQ), 123 (AL6)<br />
Heterogeneity: Chi 2 = 1.17, df = 3 (P = 0.76); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 7.07 (P < 0.00001)<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
0.005 0.1 1 10 200<br />
Favours ASMQ Favours AL<br />
158